2023/12 - Final USD(K$) | %Chg (Compare to Final) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | 2019/12 USD(K$) | |
Insurance Revenue | 17,514,000 | 7.323% | 16,319,000 | -- | -- | -- |
Interest Income | 7,820,000 | 7.610% | 7,267,000 | -- | -- | -- |
Turnover | -- | -- | -- | -- | -- | -- |
Gross Premium Income | -- | -- | -- | 37,123,000 | 35,780,000 | 34,777,000 |
Net Premium Income | -- | -- | -- | 34,444,000 | 33,328,000 | 32,611,000 |
Investment Income/(Loss) | 4,941,000 | -- | (38,647,000) | 8,660,000 | 8,159,000 | 7,808,000 |
Net Realised Gains/(Losses) on Assets | -- | -- | -- | 2,348,000 | 1,386,000 | 654,000 |
Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | 1,161,000 | 7,294,000 | 6,349,000 |
Other Income/(Loss) | 408,000 | -74.161% | 1,579,000 | 912,000 | 192,000 | (180,000) |
Total Revenues | 30,683,000 | -- | (13,482,000) | 47,525,000 | 50,359,000 | 47,242,000 |
Insurance Service Expenses | (12,078,000) | 15.756% | (10,434,000) | -- | -- | -- |
Net Expenses from Reinsurance Contracts | (345,000) | -17.661% | (419,000) | -- | -- | -- |
Net Finance (Expenses)/Income from Insurance Contracts | (10,456,000) | -- | 30,957,000 | -- | -- | -- |
Net Finance (Expenses)/Income from Reinsurance Contracts | 65,000 | -2.985% | 67,000 | -- | -- | -- |
Net Impairment Loss | (195,000) | -16.309% | (233,000) | -- | -- | -- |
Other Expenses | (2,843,000) | 24.638% | (2,281,000) | (39,046,000) | (43,072,000) | (40,007,000) |
Other Non-operating Items | 0 | -- | 0 | -- | -- | 0 |
Share of results of Associates & JCEs | (267,000) | 120.661% | (121,000) | (11,000) | (17,000) | (8,000) |
Profit / (Loss) before Taxation | 4,564,000 | 12.580% | 4,054,000 | 8,468,000 | 7,270,000 | 7,227,000 |
Taxation | (783,000) | 13.643% | (689,000) | (991,000) | (1,491,000) | (1,209,000) |
Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | (17,000) | -50.000% | (34,000) | (50,000) | 0 | (39,000) |
Others | -- | -- | -- | -- | -- | -- |
Profit/ (Loss) Attributable to Shareholders | 3,764,000 | 12.999% | 3,331,000 | 7,427,000 | 5,779,000 | 5,979,000 |
2023/12 - Final USD(K$) | %Chg (Compare to Final) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | 2019/12 USD(K$) | |
Depreciation & Amortisation | 416,000 | 6.394% | 391,000 | 407,000 | 407,000 | 340,000 |
Directors' Emoluments | 17,638 | 0.885% | 17,484 | 18,650 | 31,966 | 13,384 |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
EPS (cts) | 33.000 | 17.857% | 28.000 | 62.000 | 48.000 | 50.000 |
DPS (cts) | 20.630 | -- | 19.579 | 18.663 | 17.440 | 16.291 |
Dividend Payout Ratio (%) | 62.516% | -- | 69.926% | 30.101% | 36.334% | 32.581% |
Cash flow per share ($) | 0.948 | -- | 0.827 | 0.324 | 0.195 | 0.277 |
NBV per share ($) | 3.606 | -- | 3.792 | 4.999 | 5.225 | 4.545 |
Remarks: | Real time quote last updated: 31/10/2024 17:59 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders ($) | USD 3,314,000,000 |
%Change | 47.289% |
EPS / (LPS) | USD 0.295 |
NBV Per Share ($) | USD 3.515 |